Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
CERILLIANT™ Clorazepate dipotassium Solution, 1.0 mg/mL in Methanol (as clorazepate), Sold by MilliporeSigma™ Supelco™
Certified reference material
Supplier: MilliporeSigma Supelco C1561ML
Description
A certified analytical reference solution suitable for use in benzodiazepine testing methods by GC/MS or LC/MS for applications in clinical toxicology, urine drug testing or forensic analysis. Clorazepate dipotassium is a long-acting benzodiazepine with anxiolytic, anticonvulsant, sedative and hypnotic properties. Clorazepate dipotassium, marketed under the brand name Tranxene™, is a prodrug for nordiazepam, which is produced as an active metabolite.
Specifications
| 67-56-1 , 57109-90-7 | |
| UN 1230 - class 3 - PG 2 - Methanol, solution | |
| 408.92 | |
| 1 mL |
| C16H11ClK2N2O4 | |
| 1.0 mg/mL in methanol (as clorazepate) | |
| Ampule | |
| 9.7°C (49.5°F) - closed cup |
Safety and Handling
H331-H370
H311
Recommended Storage : -20°C
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?
CERILLIANT is a registered trademark of Cerilliant Corporation